British Biosimilars Association appoints new chair
The BBA, the representative group of biosimilar manufacturers in the UK, has announced that Kavya Gopal will become its new chair with immediate effect...
List view / Grid view
News
Quotient Sciences launches as the new global identity for Quotient Clinical
Quotient Clinical, the drug development services organisation, announces its renaming to Quotient Sciences (Quotient), following the acquisitions of Co-Formulate, QS Pharma and SeaView Research...
Stem cell therapy shows promise for macular degeneration
Studies show cell-based treatment is safe in patients with dry macular degeneration, with one showing improved vision...
ProCellics™ – first in-line and real-time bioprocess raman analyser
ProCellics™, first in-line and real-time bioprocess raman analyser, is a RESOLUTION Spectra Systems product. It offers a GMP user-friendly and easily deployed Process Analytical Technology (PAT) solution...
EMA grants marketing authorisation for subcutaneous formulation of Benlysta against lupus
The EU has approved a new subcutaneous formulation of Benlysta, as an add-on therapy in adult patients with active autoantibody-positive systemic lupus erythematosus...
FDA approves pill that tracks if patients have ingested their medication
The FDA has approved the first drug in the U.S. with a digital ingestion tracking system that records that the medication was taken...
How good design improves energy efficiency
In April 2018, changes to energy efficiency regulations will mean that every non-domestic privately rented property must have an EPC rating of at least an E. Here, John Rush, discusses three tips for improving the energy efficiency of HVAC systems in laboratories...
FDA approves Vraylar in the maintenance treatment of schizophrenia
The FDA has approved the supplemental New Drug Application for Vraylarfor the maintenance treatment of adults with schizophrenia...
PwC’s Jo Pisani joins EPR advisory board
European Pharmaceutical Review welcomes the newest member of its Editorial Advisory Board
EMA grants marketing authorisation for Prevymis against cytomegalovirus
10 November 2017 | By
The EMA has recommended granting a marketing authorisation Prevymis, an antiviral medicine that prevents CMV reactivation and disease...
Ozanimod successful in clinical trials for multiple sclerosis
The findings from the two pivotal phase 3 trials pave the way for ozanimod to enter the New Drug Approval process with the FDA...
HPV vaccine found to prevent childhood respiratory papillomatosis
The vaccine that protects against cancer-causing types of human papillomavirus also prevents an uncommon but incurable childhood respiratory disease...
Nanoshells could deliver more chemo with fewer side effects
In vitro study verifies method for remotely triggering release of cancer drugs...
Vetter expands its footprint in Asia Pacific region
Company establishes its presence in South Korea...
NHS England partners with Merck allowing people with MS immediate access to cladribine
NHS England has announced a commercial agreement that allows patients in England immediate access to the innovative new multiple sclerosis treatment...
